N-ethyl-3-imidazol-1-ylpropan-1-amine | 1011718-80-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-ethyl-3-imidazol-1-ylpropan-1-amine
• CAS: 1011718-80-1
• 化学式: C₈H₁₅N₃
• mdl: MFCD10689086
• 分子量: 153.227
• InChiKey: CFZQVOFMUPLDIR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.625
• 拓扑面积：
  29.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-ethyl-3-imidazol-1-ylpropan-1-amine 、 (2R)-2-((4-chloro-N-(5-chloro-2-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)phenyl)phenyl)sulfonamido)propyl (4-nitrophenyl) carbonate 以 N,N-二甲基甲酰胺 为溶剂， 反应 8.0h， 生成 C₃₀H₃₈Cl₂N₄O₆S
  参考文献：
  名称：

  Carbamate-appended N-alkylsulfonamides as inhibitors of γ-secretase

  摘要：

  The synthesis and gamma-secretase inhibition data for a series of carbamate-appended N-alkylsulfonamides are described. Carbamate 54 was found to significantly reduce brain A beta in transgenic mice. 54 was also found to possess markedly improved brain levels in transgenic mice compared to previously disclosed 1 and 2. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.11.102
• 作为产物：
  描述：

  1-(3-氨基丙基)咪唑 、 乙醛 在 盐酸 、 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 反应 16.0h， 生成 N-ethyl-3-imidazol-1-ylpropan-1-amine
  参考文献：
  名称：

  Carbamate-appended N-alkylsulfonamides as inhibitors of γ-secretase

  摘要：

  The synthesis and gamma-secretase inhibition data for a series of carbamate-appended N-alkylsulfonamides are described. Carbamate 54 was found to significantly reduce brain A beta in transgenic mice. 54 was also found to possess markedly improved brain levels in transgenic mice compared to previously disclosed 1 and 2. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.11.102

文献信息

• [EN] NOVEL THIOPHENE COMPOUNDS, PROCESS FOR SYNTHESIS AND USE THEREOF<br/>[FR] NOUVEAUX COMPOSÉS DE THIOPHÈNE, PROCÉDÉ DE SYNTHÈSE ET D'UTILISATION DE CEUX-CI
  申请人：AHAMMUNE BIOSCIENCES PRIVATE LTD

  公开号：WO2019043642A1

  公开（公告）日：2019-03-07

  The present invention relates to novel thiophene compounds of general Formula I, and their stereoisomers (diastereoisomers, enantiomers), pure or mixed, racemic mixtures, geometrical isomers, tautomers, pharmaceutically acceptable salts, hydrates, solvates, solid forms and mixtures thereof along with process for their preparation. The present invention discloses compounds that are useful in the treatment and prevention of autoimmune diseases.

  本发明涉及一般式I的新型噻吩化合物，以及它们的立体异构体（顺反异构体、对映异构体），纯或混合、外消旋混合物、几何异构体、互变异构体、药学上可接受的盐、水合物、溶剂合物、固体形式及其混合物，以及用于它们的制备的方法。本发明揭示了在治疗和预防自身免疫疾病中有用的化合物。
• Indenoisoquinolinone analogs and methods of use thereof
  申请人：Jagtap Prakash

  公开号：US20070049555A1

  公开（公告）日：2007-03-01

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病、肾病、神经病、勃起功能障碍或尿失禁的方法，包括向需要治疗的受体内给予有效量的Indenoisoquinolinone类似物。
• PYRROLOPYRIDINE INHIBITORS OF KINASES
  申请人：Penning Thomas D.

  公开号：US20110257152A1

  公开（公告）日：2011-10-20

  The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R 1a , R 1b , R 1c , X, and Y are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as Cdc7 and methods of treating diseases such as cancer.

  本发明涉及式（I）的化合物或药物可接受的盐，其中R1a，R1b，R1c，X和Y在说明中有定义。本发明还涉及含有所述化合物的组合物，其对于抑制Cdc7等激酶以及治疗癌症等疾病的方法是有用的。
• Benzoxazole kinase inhibitors and methods of use
  申请人：Ren Pingda

  公开号：US20100184760A1

  公开（公告）日：2010-07-22

  The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications.

  本发明提供了一些化学实体或化合物及其制药组合物，这些实体或化合物能够调节某些蛋白激酶，例如mTor、酪氨酸激酶和/或脂质激酶，例如PI3激酶。本发明还提供了使用这些组合物来调节这些激酶中的一个或多个活性的方法，特别是用于治疗应用。
• Indenoisoquinolinone Analogs and Methods of Use Thereof
  申请人：JAGTAP Prakash

  公开号：US20100004220A1

  公开（公告）日：2010-01-07

  The present invention relates to Indenoisoquinolinone Analogs, compositions comprising an effective amount of an Indenoisoquinolinone Analog and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes mellitus, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, a neurodegenerative disease, renal failure, a vascular disease, a cardiovascular disease, cancer, a complication of prematurity, cardiomyopathy, retinopathy, nephropathy, neuropathy, erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of an Indenoisoquinolinone Analog.

  本发明涉及Indenoisoquinolinone类似物，包括有效量的Indenoisoquinolinone类似物组成的组合物，以及用于治疗或预防炎症性疾病、再灌注损伤、糖尿病、糖尿病并发症、器官移植引起的再氧化损伤、缺血状况、神经退行性疾病、肾功能衰竭、血管疾病、心血管疾病、癌症、早产并发症、心肌病、视网膜病变、肾病、神经病变、勃起功能障碍或尿失禁的方法，包括向需要的受体中注射有效量的Indenoisoquinolinone类似物。